Syk and tired of current chronic GVHD therapies

被引：6

作者：

Fowler, Daniel H. ^{[1
]}

Pavletic, Steven Z. ^{[1
]}

机构：

[1] NCI, Bethesda, MD 20892 USA

来源：

BLOOD | 2015年 / 125卷 / 26期

关键词：

VERSUS-HOST-DISEASE; SPLEEN TYROSINE KINASE;

D O I：

10.1182/blood-2015-05-640672

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：3974 / +

页数：2

共 10 条

[1] Syk Tyrosine Kinase Is Critical for B Cell Antibody Responses and Memory B Cell Survival [J].

Ackermann, Jochen A. ;

Nys, Josquin ;

Schweighoffer, Edina ;

McCleary, Scott ;

Smithers, Nicholas ;

Tybulewicz, Victor L. J. .

JOURNAL OF IMMUNOLOGY, 2015, 194 (10) :4650-4656

[2] Rituximab for steroid-refractory chronic graft-versus-host disease [J].

Cutler, Corey ;

Miklos, David ;

Kim, Haesook T. ;

Treister, Nathaniel ;

Woo, Sook-Bin ;

Bienfang, Don ;

Klickstein, Lloyd B. ;

Levin, Jesse ;

Miller, Katherine ;

Reynolds, Carol ;

Macdonell, Rebecca ;

Pasek, Mildred ;

Lee, Stephanie J. ;

Ho, Vincent ;

Soiffer, Robert ;

Antin, Joseph H. ;

Ritz, Jerome ;

Alyea, Edwin .

BLOOD, 2006, 108 (02) :756-762

[3] Blockade of Syk ameliorates the development of murine sclerodermatous chronic graft-versus-host disease [J].

Doanh Le Huu ;

Kimura, Hiroshi ;

Date, Mutsumi ;

Hamaguchi, Yasuhito ;

Hasegawa, Minoru ;

Khang Tran Hau ;

Fujimoto, Manabu ;

Takehara, Kazuhiko ;

Matsushita, Takashi .

JOURNAL OF DERMATOLOGICAL SCIENCE, 2014, 74 (03) :214-221

[4] Ibrutinib treatment ameliorates murine chronic graft-versus-host disease [J].

Dubovsky, Jason A. ;

Flynn, Ryan ;

Du, Jing ;

Harrington, Bonnie K. ;

Zhong, Yiming ;

Kaffenberger, Benjamin ;

Yang, Carrie ;

Towns, William H. ;

Lehman, Amy ;

Johnson, Amy J. ;

Muthusamy, Natarajan ;

Devine, Steven M. ;

Jaglowski, Samantha ;

Serody, Jonathan S. ;

Murphy, William J. ;

Munn, David H. ;

Luznik, Leo ;

Hill, Geoffrey R. ;

Wong, Henry K. ;

MacDonald, Kelli K. P. ;

Maillard, Ivan ;

Koreth, John ;

Elias, Laurence ;

Cutler, Corey ;

Soiffer, Robert J. ;

Antin, Joseph H. ;

Ritz, Jerome ;

Panoskaltsis-Mortari, Angela ;

Byrd, John C. ;

Blazar, Bruce R. .

JOURNAL OF CLINICAL INVESTIGATION, 2014, 124 (11) :4867-4876

[5] Targeting Syk-activated B cells in murine and human chronic graft-versus-host disease [J].

Flynn, Ryan ;

Allen, Jessica L. ;

Luznik, Leo ;

MacDonald, Kelli P. ;

Paz, Katelyn ;

Alexander, Kylie A. ;

Vulic, Ante ;

Du, Jing ;

Panoskaltsis-Mortari, Angela ;

Taylor, Patricia A. ;

Poe, Jonathan C. ;

Serody, Jonathan S. ;

Murphy, William J. ;

Hill, Geoffrey R. ;

Maillard, Ivan ;

Koreth, John ;

Cutler, Corey S. ;

Soiffer, Robert J. ;

Antin, Joseph H. ;

Ritz, Jerome ;

Chao, Nelson J. ;

Clynes, Raphael A. ;

Sarantopoulos, Stefanie ;

Blazar, Bruce R. .

BLOOD, 2015, 125 (26) :4085-4094

[6] Simultaneous Assessment of Rotavirus-Specific Memory B Cells and Serological Memory after B Cell Depletion Therapy with Rituximab [J].

Herrera, Daniel ;

Rojas, Olga L. ;

Duarte-Rey, Carolina ;

Mantilla, Ruben D. ;

Angel, Juana ;

Franco, Manuel A. .

PLOS ONE, 2014, 9 (05)

[7] Calling in SYK: SYK's dual role as a tumor promoter and tumor suppressor in cancer [J].

Krisenko, Mariya O. ;

Geahlen, Robert L. .

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2015, 1853 (01) :254-263

[8] Spleen tyrosine kinase (Syk) is a potent target for GvHD prevention at different cellular levels [J].

Leonhardt, F. ;

Zirlik, K. ;

Buchner, M. ;

Prinz, G. ;

Hechinger, A-K ;

Gerlach, U. V. ;

Fisch, P. ;

Schmitt-Graeff, A. ;

Reichardt, W. ;

Zeiser, R. .

LEUKEMIA, 2012, 26 (07) :1617-1629

[9]

Lucas MC, 2014, FUTURE MED CHEM, V6, P1811, DOI [10.4155/FMC.14.126, 10.4155/fmc.14.126]

[10] 2014 National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: Preface to the Series [J].

Pavletic, Steven Z. ;

Vogelsang, Georgia B. ;

Lee, Stephanie J. .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (03) :387-388

← 1 →